Jae-sik Shin

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

TP53 and DNA-PK as potential biomarkers for enhanced efficacy of Olaparib in colorectal cancer.

TP53 and DNA-PK as potential biomarkers for enhanced efficacy of Olaparib in colorectal cancer.

Journal: Investigational new drugs

Published: April 04, 2025

The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy.

The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy.

Journal: Cancer immunology research

Published: October 03, 2023

Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.

Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.

Journal: Cell death and differentiation

Published: March 13, 2023

CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.

CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.

Journal: Anticancer research

Published: December 30, 2021

Mutation SVCT2 promotes cell proliferation, invasion and migration in colorectal cancer.

Mutation SVCT2 promotes cell proliferation, invasion and migration in colorectal cancer.

Journal: Journal of Cancer

Published: December 23, 2020

Role of p53 in transcriptional repression of SVCT2.

Role of p53 in transcriptional repression of SVCT2.

Journal: Molecular biology reports

Published: October 20, 2020

Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells.

Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells.

Journal: Redox biology

Published: June 15, 2020

Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.

Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.

Journal: Biochemical and biophysical research communications

Published: April 05, 2020

Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells.

Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells.

Journal: Investigational new drugs

Published: March 07, 2020

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.

Journal: British journal of cancer

Published: March 13, 2018

Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.

Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.

Journal: Toxicology in vitro : an international journal published in association with BIBRA

Published: February 25, 2017

Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.

Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.

Journal: Toxicology letters

Published: March 14, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026